Publications by authors named "Murat Inanc"

Claim this Profile
D
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug Monitoring.
Shivani Garg, Benoît Blanchet, Yann Nguyen, Fauzia Hollnagel, Ada Clarke, Murat Inanc

Arthritis Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality.
Yann L C Becker, Éric Boilard, Emmanuelle Rollet-Labelle, Christian Lood, Anne-Sophie Julien, Murat Inanc

Ann Rheum Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypes of patients with more than one autoinflammatory disease-associated gene variant: overlapping and mixed autoinflammatory disorders.
Shirkhan Amikishiyev, Tuğba Kalaycı, Rabia Deniz, Lale Soltanova, Bersan Sen, Murat Inanc

Rheumatology (Oxford)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avascular necrosis in patients with systemic lupus erythematosus: Prevalence, associations, risk factors and outcome.
Çiğdem Çetin, Deniz Seyithanoğlu, Lezgin Mert, Yasemin Yalçınkaya, Ahmet Gül

Lupus· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between NETosis findings and disease activity in Behçet's disease: an exploratory study.
Erdem Bektas, Rabia Deniz, Zeliha Emrence, Sema Sirma Ekmekci, Neslihan Abaci, Murat Inanc

Clin Exp Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for Pulmonary Hypertension in Connective Tissue Diseases: Literature Review and Multidisciplinary Consensus Statement.
Alper Sarı, Duygu Temiz Karadağ, Mustafa Erdoğan, Müçteba Enes Yayla, Büşra Fırlatan Yazgan

Anatol J Cardiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of different field tests in relation to balance, daily living activities, and quality of life in pulmonary hypertension.
Ozge Ertan Harputlu, Goksen Kuran Aslan, Buket Akıncı, Ahmet Kaya Bilge, Murat Inanc

Monaldi Arch Chest Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation of hydroxychloroquine due to suspected retinal toxicity in systemic lupus erythematosus and the role of multimodal imaging.
Burak Ince, Mehmet Bedii Oğurel, Zafer Cebeci, Yavuz Burak Tor, Yasemin Yalçinkaya

Turk J Med Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERN ReCONNET-SLICC-SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations.
Laurent Arnaud, Guillermo Ruiz-Irastorza, Cynthia Aranow, Sasha Bernatsky, Maria Dall'Era

Lancet Rheumatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient elastography measurements of the liver and transplanted kidney in patients with AA amyloidosis: a cross-sectional comparative study.
Murat Bektaş, Bilger Çavuş, Besim Fazıl Ağargün, İbrahim Volkan Şenkal, Nevzat Koca

Rheumatol Int· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Damage accrual and predictors of mortality in ANCA-associated vasculitis: a retrospective observational study.
Murat Bektaş, Burak Ince, Sibel Zaralı, Übeyde Ayşe Gülseren, Ece Ük

Rheumatol Int· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality and associated factors in patients with systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease: A long-term follow-up study.
Shirkhan Amikishiyev, Yasemin Yalçınkaya, Konul Mammadova, Numune Aliyeva, Gorkem Durak, Murat Inanc

Mod Rheumatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budd Chiari syndrome associated with antiphospholipid syndrome: Clinical characteristics and prognosis of 17 patients from single center.
Ömer Uludağ, Akın Işık, Ege Sinan Torun, Burak Alkaç, Yasemin Yalçınkaya

Lupus· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal disease activity and associated factors in patients with psoriatic arthritis: cross-sectional study from a single center.
Murat Bektas, Berk Çelik, Burak İnce, Yasemin Yalçınkaya, Bahar Artım Esen

Reumatologia· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABO blood groups and increased risk for the development of vascular involvement in Behçet's disease.
Erdem Bektas, Abdülkadir Büyükdemir, Yasemin Yalcinkaya, Bahar Artim Esen, Murat Inanc

Clin Exp Rheumatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Megan R W Barber, Manuel Francisco Ugarte-Gil, John G Hanly, Murray B Urowitz, Yvan St-Pierre, Murat Inanc

Ann Rheum Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum and urine interferon-inducible protein 10, galectin-9, and SIGLEC-1 as biomarkers of disease activity in systemic lupus erythematosus.
Şafak Mirioğlu, Suzan Çinar, Ömer Uludağ, Erdem Gürel, Sibel Varelci

Turk J Med Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu's arteritis.
Sema Kaymaz-Tahra, Ozun Bayindir, Burak Ince, Ozlem Ozdemir İsik, Muhammet Emin Kutu, Murat Inanc

Semin Arthritis Rheum· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and the effects of spondyloarthritis-spectrum disorders on the clinical course and management of Takayasu arteritis: an observational retrospective study.
Kerem Abacar, Sema Kaymaz-Tahra, Özün Bayındır, Burak İnce, Muhammet Emin Kutu

Clin Rheumatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients.
Aslıhan Avanoglu Güler, Büşra Özçimen, Mesude Seda Aydoğdu, Alper Sari, Aliyeva Numune

Turk J Med Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of baseline F-18 FDG positron emission tomography in the diagnosis and assessment of giant cell arteritis.
Burak Ince, Emine Göknur Işik, Zeynep Gözde Özkan, Yasemin Yalçinkaya, Bahar Artim Esen

Turk J Med Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?
Ömer Uludağ, Suzan Çinar, Thomas McDonnell, Erhan Çene, Yasemin Yalçinkaya

Turk J Med Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of rituximab on disease activity, severity, and disease-related damage in patients with immunosuppressive-resistant systemic sclerosis.
Yasemin Yalçinkaya, Bahar Artim Esen, Shirkhan Amikishiyev, Numuna Aliyeva, Ahmet Gül

Turk J Med Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus.
Eugene Krustev, John G Hanly, Ricky Chin, Katherine A Buhler, Murray B Urowitz, Murat Inanc

Lupus Sci Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(18)F-fluorodeoxyglucose uptake by positron emission tomography in patients with IPAH and CTEPH.
Celik Sumer, Gulfer Okumus, Emine Goknur Isik, Cuneyt Turkmen, Ahmet Kaya Bilge, Murat Inanc

Pulm Circ· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis